In a press release issued March 18, 2015, Heraeus Medical Components, a global business unit of Heraeus Holding GmbH, announced that it will acquire NeoMetrics, Inc. According to the press release, Heraeus Medical Components has executed a share purchase agreement to acquire 100% of the stock in the privately owned NeoMetrics. The transaction is expected to occur within the next 60 days. Further details of the deal were not disclosed.
Regarding the acquisition, Dr. Nicolas Guggenheim, President of Heraeus Medical Components, said:
With this acquisition, Heraeus Medical Components will add new interventional technologies to augment their leadership position as a sourcing solution for the world’s medical device companies. We are excited about the potential growth opportunities within the interventional field.
According to its website, Heraeus Medical Components “provides expert, comprehensive medical component manufacturing services, meeting a broad range of functional demands” and provides a range of medical device products.
NeoMetrics’ website indicates that it is headquartered in Plymouth, Minnesota, was founded in 2001, and operates exclusively as an OEM partner of medical device companies. Its website touts expertise in a wide variety of medical device guidewires. The USPTO Assignment Database lists two patents, among several applications, assigned to Neometrics:
- U.S. Patent No. 8,801,633, entitled “High-Modulus Superelastic Alloy Wire for Medical and Dental Purposes”
- U.S. Patent No. 8,308,658, entitled “Medical Guidewire”